Developer docs
API playgroundTry for free, no card

Search company profiles

Fraunhofer MEVIS

Full company profile

uuid0033yhr

Namestring
Fraunhofer MEVIS
Legal namestring
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Fraunhofer MEVIS, formally the Fraunhofer Institute for Digital Medicine, is a non-profit applied research institute headquartered on the University of Bremen campus and operating since 1995 as a constituent entity of the Fraunhofer-Gesellschaft. Its work spans medical image computing, AI/ML for medical imaging, image-guided therapy, computational pathology, and radiation therapy planning. The institute develops a portfolio of named software solutions including OncoChange (AI-driven CT-based tumor follow-up), CuraMate and HistokatFusion (computational pathology with digital biomarkers), CaFuR (multicycle real-time cardiac MRI analysis), gammaSTAR (radiation therapy planning and dosimetry), SAFIR (a modular framework for needle-based interventional workflows), the Liver Explorer App (tablet-based surgical planning showcased at an Apple Special Event), MEVIS draw (free analysis tooling), and the NAKO-Viewer (digital infrastructure for Germany's largest population health study).

Technically, the institute combines proprietary algorithms in medical image registration, real-time MRI reconstruction, segmentation, simulation, and visualization with AI/ML pipelines for computer vision, predictive analytics, and — per a Science Advances publication — generative synthesis of radiographs. It is staffed by scientists with dual academic-clinical affiliations, multiple Highly Cited Researchers, and ISMRM Fellows, and operates from a purpose-built 2,600 sqm facility occupied in May 2021 with capacity for 210 workstations, plus a project group in Lübeck.

Commercially, Fraunhofer MEVIS does not sell SaaS or standalone products at list prices. Revenue is generated through a mix of (i) base funding from the Fraunhofer Society (German federal and state government appropriations), (ii) competitive third-party research grants from BMBF, DFG, and EU programs such as ERDF, and (iii) contract research, technology licensing, and co-development with pharmaceutical companies, medical device manufacturers (e.g., imaging oncology platforms), academic medical centers (UKE, University of Bern), and large public health programs (NAKO German National Cohort). Go-to-market is sales-led through collaborative R&D rather than transactional selling, with distribution via technology licensing, joint development, and free tools (MEVIS draw) used as awareness funnels into commercial engagements.

Short descriptiontext

Fraunhofer MEVIS is a non-profit Fraunhofer Institute that develops AI-driven medical imaging, image-guided therapy, and computational pathology software for hospitals, pharma, and medical device manufacturers, distributing technology via research collaboration and licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBremen, Germany
HQ citystring
Bremen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging software, image-guided therapy, computational pathology, AI diagnostic software, radiation therapy planning
Industry5 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Computer Systems Design Services541512
  • Surgical and Medical Instrument Manufacturing339112
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Computer Integrated Systems Design7373
Product category
Medical Imaging Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research Funding
TypeProfessional Services
Description

Fraunhofer MEVIS receives core funding from the Fraunhofer Society, which is funded by German federal and state governments. Additional project funding comes from BMBF (Federal Ministry of Education and Research), DFG (German Research Foundation), and EU research programs.

mevis.fraunhofer.de
2Industry Collaborations
TypeLicensing Royalties
Description

Collaborative R&D projects with pharmaceutical companies, medical device manufacturers, and healthcare providers for technology development and validation.

mevis.fraunhofer.de
3Technology Transfer
TypeLicensing Royalties
Description

Licensing of developed software solutions and algorithms to medical device companies and healthcare technology providers.

mevis.fraunhofer.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1OncoChange
Description

AI-driven software solution that enables radiologists to perform CT-based tumor follow-up assessments in clinical practice more efficiently and reliably.

mevis.fraunhofer.de
+5 more records
Core offering1 text field

Fraunhofer MEVIS develops software solutions for image- and data-supported early detection, diagnosis, and therapy, spanning medical image computing, AI-driven diagnostics, image-guided therapy planning, and computational pathology. It commercializes these capabilities through research collaborations, contract R&D, and licensing of proprietary algorithms to hospitals, pharmaceutical companies, and medical-device manufacturers, alongside a limited set of free-standing tools (e.g., MEVIS draw).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • AI-driven tumor follow-up enables more efficient and reliable CT-based tumor assessments in clinical practice
+2 more records
Product overview1 text field

Fraunhofer MEVIS develops real-world software solutions for computer-aided medicine, bridging medical imaging, image-guided therapy, and healthcare informatics. The institute operates as a research and technology transfer organization with a portfolio of named products including diagnostic software solutions (OncoChange for AI-driven tumor follow-up, CuraMate with multiple sub-products for reader studies, education and AI development, HistokatFusion for computational pathology), imaging physics tools (gammaSTAR for radiation therapy), real-time MRI cardiac analysis (CaFuR), and image-guided therapy solutions (SAFIR for needle-based interventions, Liver Explorer App). Additional offerings include free analysis software (MEVIS draw) and digital infrastructure services (NAKO-Viewer for national health studies). The products span diagnostic software, image-guided therapy, clinical trials and pharma support, and computational pathology.

Product and service9 records
1OncoChange
CategoryDiagnostic Software (AI Tumor Follow-up)
Description

AI-driven software solution that enables radiologists to perform CT-based tumor follow-up assessments in clinical practice more efficiently and reliably, automatically analyzing tumor progression over time.

2CuraMate
CategoryDiagnostic Software (Clinical Research and Education)
Description

Comprehensive medical imaging solution with sub-products including CuraMate Reader Studies for clinical research, CuraMate Education for training, and CuraMate AI Development for AI-powered diagnostic tools.

3HistokatFusion
CategoryComputational Pathology Software
Description

Solution for computational pathology combining histological data analysis capabilities.

4gammaSTAR
CategoryImaging Physics / Radiation Therapy Planning
Description

Advanced imaging physics solution for radiation therapy planning and visualization, supporting radiofrequency ablation procedures for liver tumors.

5CaFuR
CategoryReal-Time Cardiac MRI Software
Description

Multicycle real-time MRI analysis software for cardiac diagnosis, consisting of accelerated MRI acquisition and a complete software solution for automated cardiac function analysis that identifies breathing and heart contraction phases independently of ECG information.

6SAFIR
CategoryImage-Guided Therapy Software
Description

Modular framework for software assistance during needle-based interventions, supporting the entire interventional workflow from planning to assessment using segmentation, registration, simulation, optimization, and visualization methodology.

7MEVIS draw
CategoryImage and Data Analysis Software
Description

Free software tool for medical image analysis and annotation, available for download for Windows, Linux, and macOS platforms.

8NAKO-Viewer
CategoryDigital Health Study Infrastructure
Description

Digital infrastructure solution for Germany's largest health study (NAKO), providing medical image data management for the German National Cohort.

9Liver Explorer App
CategoryImage-Guided Therapy Software
Description

Tablet-based application for liver surgeons providing access to and visualization of planning data during liver surgery, originally demonstrated at an Apple Special Event.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for immersive artwork 'The Tides Within Us' exploring oxygen flow through the human cardiovascular system using VR and immersive technologies. MLF is one of the world's leading immersive art collectives.

2York Mediale
Strategic tierMinorTypeStrategic or Co-development Partner
Description

International new media arts charity in York, UK (UNESCO Creative City of Media Arts) collaborating on 'The Tides Within Us' presentation.

mevis.fraunhofer.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperated with University of Bern and leading liver center in Shanghai on navigated liver surgery research and development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative alliance including launch of AI Center for Health Care. Fraunhofer MEVIS perpetuates collaboration with universities in Bremen.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on AI4Prevention position paper addressing disease prevention and early detection through AI.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Close research partnerships with University of Bremen including Horst Hahn accepting professorship. NAKO-Viewer development in MR laboratory.

7Harvard Medical School
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prestigious appointment of MEVIS researcher at Harvard for academic exchange and collaboration.

mevis.fraunhofer.de
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Cloud-native medical imaging AI platform with FDA-cleared cardiac MRI and CT modules; directly comparable to MEVIS's CaFuR real-time cardiac MRI and broader imaging AI efforts.

TypeBroad incumbent
Description

Imaging, interventional, and clinical informatics incumbent with AI-enabled diagnostic and image-guided therapy offerings; comparable in product breadth and in serving academic medical centers and large hospital systems in Europe.

TypeEmerging player
Description

AI-driven computational pathology company developing digital biomarkers from pathology images; directly comparable to MEVIS's CuraMate and HistokatFusion computational pathology programs.

TypeBroad incumbent
Description

Imaging equipment and AI-software incumbent with Edison platform; relevant peer because its radiology AI applications and PACS integrations directly compete with the clinical-use cases MEVIS targets (CT, MRI, oncology follow-up).

TypeEmerging player
Description

VC-backed AI imaging company focused on CT workflow triage and radiology AI; directly comparable to MEVIS's OncoChange-style CT-based clinical decision support and AI tumor follow-up capabilities.

TypeBroad incumbent
Description

Global medical imaging and diagnostics incumbent whose AI-Rad Companion and digital health portfolio overlap directly with MEVIS's AI imaging and image-guided therapy R&D; competes as a downstream commercializer of similar algorithms.

TypeOthers
Description

Compute and developer-platform vendor whose Clara imaging AI toolkit is used by MEVIS researchers (NVIDIA Demo Contest winner) and shapes the ecosystem in which medical-imaging AI is built and deployed.

TypeDirect peer
Description

Imaging CRO and AI imaging company focused on oncology trial endpoints and tumor follow-up assessment; directly comparable to MEVIS's OncoChange, computational pathology, and pharma imaging biomarker work for clinical trials.

TypeDirect peer
Description

Germany's largest publicly funded biomedical research institute; comparable as a peer applied-research organization with overlapping oncology imaging, radiomics, and AI-driven diagnostics programs that compete for BMBF/DFG funding and academic talent.

TypeDirect peer
Description

Academic medical center with a globally recognized medical-imaging AI group (e.g., Diagnostic Image Analysis Group); comparable as a research-driven developer of imaging AI algorithms deployed in clinical radiology workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fraunhofer MEVIS

Medical Imaging Softwaremevis.fraunhofer.de

Fraunhofer MEVIS is a non-profit Fraunhofer Institute that develops AI-driven medical imaging, image-guided therapy, and computational pathology software for hospitals, pharma, and medical device manufacturers, distributing technology via research collaboration and licensing.

What Fraunhofer MEVIS does

Fraunhofer MEVIS, formally the Fraunhofer Institute for Digital Medicine, is a non-profit applied research institute headquartered on the University of Bremen campus and operating since 1995 as a constituent entity of the Fraunhofer-Gesellschaft. Its work spans medical image computing, AI/ML for medical imaging, image-guided therapy, computational pathology, and radiation therapy planning. The institute develops a portfolio of named software solutions including OncoChange (AI-driven CT-based tumor follow-up), CuraMate and HistokatFusion (computational pathology with digital biomarkers), CaFuR (multicycle real-time cardiac MRI analysis), gammaSTAR (radiation therapy planning and dosimetry), SAFIR (a modular framework for needle-based interventional workflows), the Liver Explorer App (tablet-based surgical planning showcased at an Apple Special Event), MEVIS draw (free analysis tooling), and the NAKO-Viewer (digital infrastructure for Germany's largest population health study).

Technically, the institute combines proprietary algorithms in medical image registration, real-time MRI reconstruction, segmentation, simulation, and visualization with AI/ML pipelines for computer vision, predictive analytics, and — per a Science Advances publication — generative synthesis of radiographs. It is staffed by scientists with dual academic-clinical affiliations, multiple Highly Cited Researchers, and ISMRM Fellows, and operates from a purpose-built 2,600 sqm facility occupied in May 2021 with capacity for 210 workstations, plus a project group in Lübeck.

Commercially, Fraunhofer MEVIS does not sell SaaS or standalone products at list prices. Revenue is generated through a mix of (i) base funding from the Fraunhofer Society (German federal and state government appropriations), (ii) competitive third-party research grants from BMBF, DFG, and EU programs such as ERDF, and (iii) contract research, technology licensing, and co-development with pharmaceutical companies, medical device manufacturers (e.g., imaging oncology platforms), academic medical centers (UKE, University of Bern), and large public health programs (NAKO German National Cohort). Go-to-market is sales-led through collaborative R&D rather than transactional selling, with distribution via technology licensing, joint development, and free tools (MEVIS draw) used as awareness funnels into commercial engagements.

Fraunhofer MEVIS firmographics

Firmographics
Name
Fraunhofer MEVIS
Legal name
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Website
https://mevis.fraunhofer.de
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
101–250 employees
Short description
Fraunhofer MEVIS is a non-profit Fraunhofer Institute that develops AI-driven medical imaging, image-guided therapy, and computational pathology software for hospitals, pharma, and medical device manufacturers, distributing technology via research collaboration and licensing.
Ownership category
akta.pro rank

Fraunhofer MEVIS industry classification

Industry
Product category
Medical Imaging Software
NAICS
Scientific Research and Development Services (5417), Computer Systems Design Services (541512), Surgical and Medical Instrument Manufacturing (339112)
SIC
Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medical imaging software
  • Image-guided therapy
  • Computational pathology
  • AI diagnostic software
  • Radiation therapy planning

Where Fraunhofer MEVIS is headquartered

Location

Headquarters

HQ city
Bremen
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Fraunhofer MEVIS business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Research Funding: Fraunhofer MEVIS receives core funding from the Fraunhofer Society, which is funded by German federal and state governments. Additional project funding comes from BMBF (Federal Ministry of Education and Research), DFG (German Research Foundation), and EU research programs.
  2. Industry Collaborations: Collaborative R&D projects with pharmaceutical companies, medical device manufacturers, and healthcare providers for technology development and validation.
  3. Technology Transfer: Licensing of developed software solutions and algorithms to medical device companies and healthcare technology providers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Fraunhofer MEVIS product offering

Product offering

Core offering

Fraunhofer MEVIS develops software solutions for image- and data-supported early detection, diagnosis, and therapy, spanning medical image computing, AI-driven diagnostics, image-guided therapy planning, and computational pathology. It commercializes these capabilities through research collaborations, contract R&D, and licensing of proprietary algorithms to hospitals, pharmaceutical companies, and medical-device manufacturers, alongside a limited set of free-standing tools (e.g., MEVIS draw).

Product overview

Fraunhofer MEVIS develops real-world software solutions for computer-aided medicine, bridging medical imaging, image-guided therapy, and healthcare informatics. The institute operates as a research and technology transfer organization with a portfolio of named products including diagnostic software solutions (OncoChange for AI-driven tumor follow-up, CuraMate with multiple sub-products for reader studies, education and AI development, HistokatFusion for computational pathology), imaging physics tools (gammaSTAR for radiation therapy), real-time MRI cardiac analysis (CaFuR), and image-guided therapy solutions (SAFIR for needle-based interventions, Liver Explorer App). Additional offerings include free analysis software (MEVIS draw) and digital infrastructure services (NAKO-Viewer for national health studies). The products span diagnostic software, image-guided therapy, clinical trials and pharma support, and computational pathology.

Differentiator

Problem solved

Functional benefit

Brands

  • OncoChange: AI-driven software solution that enables radiologists to perform CT-based tumor follow-up assessments in clinical practice more efficiently and reliably.
  • HistokatFusion
  • CuraMate
  • gammaSTAR
  • CaFuR
  • SAFIR

Products and services

  • OncoChange AI-driven software solution that enables radiologists to perform CT-based tumor follow-up assessments in clinical practice more efficiently and reliably, automatically analyzing tumor progression over time.
  • CuraMate Comprehensive medical imaging solution with sub-products including CuraMate Reader Studies for clinical research, CuraMate Education for training, and CuraMate AI Development for AI-powered diagnostic tools.
  • HistokatFusion Solution for computational pathology combining histological data analysis capabilities.
  • gammaSTAR Advanced imaging physics solution for radiation therapy planning and visualization, supporting radiofrequency ablation procedures for liver tumors.
  • CaFuR Multicycle real-time MRI analysis software for cardiac diagnosis, consisting of accelerated MRI acquisition and a complete software solution for automated cardiac function analysis that identifies breathing and heart contraction phases independently of ECG information.
  • SAFIR Modular framework for software assistance during needle-based interventions, supporting the entire interventional workflow from planning to assessment using segmentation, registration, simulation, optimization, and visualization methodology.
  • MEVIS draw Free software tool for medical image analysis and annotation, available for download for Windows, Linux, and macOS platforms.
  • NAKO-Viewer Digital infrastructure solution for Germany's largest health study (NAKO), providing medical image data management for the German National Cohort.
  • Liver Explorer App Tablet-based application for liver surgeons providing access to and visualization of planning data during liver surgery, originally demonstrated at an Apple Special Event.

Quantifiable outcome

  • AI-driven tumor follow-up enables more efficient and reliable CT-based tumor assessments in clinical practice
  • +2 more outcomes

Companies that use Fraunhofer MEVIS

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Fraunhofer MEVIS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature10 records

Fraunhofer MEVIS partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Marshmallow Laser Feast (MLF)coreStrategic or Co-development PartnerResearch partnership for immersive artwork 'The Tides Within Us' exploring oxygen flow through the human cardiovascular system using VR and immersive technologies. MLF is one of the world's leading immersive art collectives.
  • York MedialeminorStrategic or Co-development PartnerInternational new media arts charity in York, UK (UNESCO Creative City of Media Arts) collaborating on 'The Tides Within Us' presentation.
  • University of BerncoreStrategic or Co-development PartnerCooperated with University of Bern and leading liver center in Shanghai on navigated liver surgery research and development.
  • U Bremen Research AlliancecoreStrategic or Co-development PartnerCollaborative alliance including launch of AI Center for Health Care. Fraunhofer MEVIS perpetuates collaboration with universities in Bremen.
  • Leibniz Institute for Prevention Research and Epidemiology (BIPS)coreStrategic or Co-development PartnerCollaboration on AI4Prevention position paper addressing disease prevention and early detection through AI.
  • University of BremencoreStrategic or Co-development PartnerClose research partnerships with University of Bremen including Horst Hahn accepting professorship. NAKO-Viewer development in MR laboratory.
  • Harvard Medical SchoolminorStrategic or Co-development PartnerPrestigious appointment of MEVIS researcher at Harvard for academic exchange and collaboration.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Fraunhofer MEVIS competitors and assessment

Company assessment

Emerging players

  • Arterys: Cloud-native medical imaging AI platform with FDA-cleared cardiac MRI and CT modules; directly comparable to MEVIS's CaFuR real-time cardiac MRI and broader imaging AI efforts.
  • Paige.AI: AI-driven computational pathology company developing digital biomarkers from pathology images; directly comparable to MEVIS's CuraMate and HistokatFusion computational pathology programs.
  • Aidoc: VC-backed AI imaging company focused on CT workflow triage and radiology AI; directly comparable to MEVIS's OncoChange-style CT-based clinical decision support and AI tumor follow-up capabilities.

Broad incumbents

  • Philips Healthcare: Imaging, interventional, and clinical informatics incumbent with AI-enabled diagnostic and image-guided therapy offerings; comparable in product breadth and in serving academic medical centers and large hospital systems in Europe.
  • GE HealthCare: Imaging equipment and AI-software incumbent with Edison platform; relevant peer because its radiology AI applications and PACS integrations directly compete with the clinical-use cases MEVIS targets (CT, MRI, oncology follow-up).
  • Siemens Healthineers: Global medical imaging and diagnostics incumbent whose AI-Rad Companion and digital health portfolio overlap directly with MEVIS's AI imaging and image-guided therapy R&D; competes as a downstream commercializer of similar algorithms.

Others

  • NVIDIA Clara / NVIDIA Healthcare: Compute and developer-platform vendor whose Clara imaging AI toolkit is used by MEVIS researchers (NVIDIA Demo Contest winner) and shapes the ecosystem in which medical-imaging AI is built and deployed.

Direct peers

  • Median Technologies: Imaging CRO and AI imaging company focused on oncology trial endpoints and tumor follow-up assessment; directly comparable to MEVIS's OncoChange, computational pathology, and pharma imaging biomarker work for clinical trials.
  • German Cancer Research Center (DKFZ): Germany's largest publicly funded biomedical research institute; comparable as a peer applied-research organization with overlapping oncology imaging, radiomics, and AI-driven diagnostics programs that compete for BMBF/DFG funding and academic talent.
  • Radboud University Medical Center (Radboudumc): Academic medical center with a globally recognized medical-imaging AI group (e.g., Diagnostic Image Analysis Group); comparable as a research-driven developer of imaging AI algorithms deployed in clinical radiology workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Fraunhofer MEVIS social profiles

Digital presence

Fraunhofer MEVIS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fraunhofer MEVIS leadership team

Management profile

Number of profiles

Profiles4 records

Fraunhofer MEVIS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fraunhofer MEVIS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fraunhofer MEVIS

What does Fraunhofer MEVIS do?

Fraunhofer MEVIS develops software solutions for image- and data-supported early detection, diagnosis, and therapy, spanning medical image computing, AI-driven diagnostics, image-guided therapy planning, and computational pathology. It commercializes these capabilities through research collaborations, contract R&D, and licensing of proprietary algorithms to hospitals, pharmaceutical companies, and medical-device manufacturers, alongside a limited set of free-standing tools (e.g., MEVIS draw).

Is Fraunhofer MEVIS a public or private company?

Fraunhofer MEVIS is a private company. It is classified as state government owned and is currently operating.

When was Fraunhofer MEVIS founded?

Fraunhofer MEVIS was founded in 1995. It employs 101 to 250 people.

Where is Fraunhofer MEVIS based?

Fraunhofer MEVIS is headquartered in Bremen, Germany, in the Europe region.

How does Fraunhofer MEVIS make money?

Three revenue lines are on record. Research Funding is the primary driver. The others are industry Collaborations and technology Transfer.

Who are Fraunhofer MEVIS's main competitors?

Emerging players on record are Arterys, Paige.AI and Aidoc. Broad incumbents are Philips Healthcare, GE HealthCare and Siemens Healthineers. NVIDIA Clara / NVIDIA Healthcare is listed as an others. Direct peers are Median Technologies, German Cancer Research Center (DKFZ) and Radboud University Medical Center (Radboudumc).

Does Fraunhofer MEVIS have an API?

No public API is recorded for Fraunhofer MEVIS.

What industry is Fraunhofer MEVIS in?

Fraunhofer MEVIS's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals